Slingsby Brian Taylor's Form 4 filing
Mineralys Therapeutics, Inc. (MLYS) · filed Nov 21, 2025
- Accession no.
- 0001933414-25-000156
- Filed
- Nov 21, 2025, 6:07 PM ET
- Trade date
- Nov 20, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $43.4M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Slingsby Brian TaylorCIK 0001963901 | Director, 10% Owner |
| Catalys Pacific Fund, LPCIK 0001746274 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | Common Stock | SSaleDisposed | −1,000,000 | $43.35 | −$43,350,000 | 7,903,838 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.